In controlled research settings, studies on Trinity-X have observed improvements in systolic and diastolic blood pressure readings, enhanced lipid profiles including LDL markers, and changes in visceral adiposity measurements in animal models
As per Madalina Ionescu et al., The marked enhancement of trough GH levels by continuous GHRH stimulation implicates the importance of this effect on increasing IGF-I
Legal Responsibilities & Consent
The 10 mg vial gives about 66 doses at 150 mcg
Key Takeaways on AOD 9604 Investigational status: AOD 9604 is not an FDA-approved medication for fat loss or any other indication, which is why medical supervision is essential
Clinical trials confirmed that AOD-9604 has no negative impact on glucose metabolism, representing a significant safety advantage for individuals with metabolic concerns